Rigel Pharmaceuticals
RIGL
#7454
Rank
S$0.43 B
Marketcap
$24.56
Share price
6.18%
Change (1 day)
36.52%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2024 (TTM): S$34.65 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are S$0.17 Billion. , an increase over its 2023 earnings that were of -S$24.57 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024 S$35.44 M-244.27%
2023 -S$24.57 Million-66.79%
2022 -S$74 Million340.73%
2021 -S$16.79 Million-56.15%
2020 -S$38.29 Million-57.34%
2019 -S$89.77 Million-7.66%
2018 -S$97.21 Million-9.47%
2017 -S$0.11 Billion24.46%
2016 -S$86.28 Million23.63%
2015 -S$69.78 Million-43.29%
2014 -S$0.13 Billion2.5%
2013 -S$0.13 Billion
2010 S$51.05 M-133.97%
2009 -S$0.16 Billion-18.49%
2008 -S$0.19 Billion71.91%
2007 -S$0.11 Billion84.74%
2006 -S$58.06 Million-10.17%
2005 -S$64.63 Million-15.73%
2004 -S$76.69 Million39.29%
2003 -S$55.06 Million10.3%
2002 -S$49.92 Million48.3%
2001 -S$33.67 Million-2.13%
2000 -S$34.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.18 Billion-596.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.14 Billion-474.55%๐Ÿ‡บ๐Ÿ‡ธ USA
S$14.06 B 39,593.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$6.21 B 17,435.38%๐Ÿ‡บ๐Ÿ‡ธ USA